Evidence map›Paper›PMID 38081968›Full record

ArticlePediatric cardiology2024

Transcatheter Ventricular Septal Defect Closure with Lifetech™ Konar-MF Occluder in Infants Under 10 kg with Only Using Venous Access.

İbrahim Ece, Denizhan Bağrul, Ahmet Vedat Kavurt, Harun Terin, Gülşah Torun, Serhat Koca, Ayşe Esin Kibar Gül

Abstract read
PubMed Publisher
In one paragraph

Article in Pediatric cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

İbrahim EceDepartment of Pediatric Cardiology, University of Health Sciences, Ankara City Hospital, Üniversiteler Mahallesi 1604, Cadde No 9 Çankaya, Ankara, Turkey.
Denizhan BağrulDepartment of Pediatric Cardiology, University of Health Sciences, Ankara City Hospital, Üniversiteler Mahallesi 1604, Cadde No 9 Çankaya, Ankara, Turkey. denizhanbagrul@yahoo.com.
Ahmet Vedat KavurtDepartment of Pediatric Cardiology, Ministry of Health, Ankara City Hospital, Ankara, Turkey.
Harun TerinDepartment of Pediatric Cardiology, Ministry of Health, Ankara City Hospital, Ankara, Turkey.
Gülşah TorunDepartment of Pediatric Cardiology, Ministry of Health, Ankara City Hospital, Ankara, Turkey.
Serhat KocaDepartment of Pediatric Cardiology, University of Health Sciences, Ankara City Hospital, Üniversiteler Mahallesi 1604, Cadde No 9 Çankaya, Ankara, Turkey.
Ayşe Esin Kibar GülDepartment of Pediatric Cardiology, University of Health Sciences, Ankara City Hospital, Üniversiteler Mahallesi 1604, Cadde No 9 Çankaya, Ankara, Turkey.
Çankaya University · TRMinistry of Health · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcatheter closure of VSD remains a complex procedure in infants with technical challenges and carries the risk of significant complications, due to its complex anatomical morphology and closed proximity to the atrioventricular valves and the conduction system. In this article, we presented transcatheter VSD closure in infants under 10 kg using the Lifetech Konar-MF device via only venous route without TEE guidance and arterial access. Between January 2021 and May 2023, a total of 34 patients weighing less than 10 kg who underwent transcatheter VSD closure antegradely with Lifetech™ Konar-Multifunctional (MF) occluder were included in the study. The mean age of the patients was 8.1 (3.5-35) months. Average weight was 6.5 kg (range 4.5-10 kg). VSD was perimembranous in 27 patients (79.4%). Successful device placement was achieved in all 34 patients. However, device embolization occurred in three patients. One of the patients was successfully implanted with a one size larger device, the surgical closure was performed other two cases. TR occurred in seven patients (20.6%) after releasing devices. None of the patients developed complete heart block. Right bundle branch block developed in two patients. Residual shunt was observed in 9 patients (six small, two moderate, and one large). During follow-up, residual shunt disappeared in six of these patients and only mild residual shunt remained in the other four patients which have not required any further intervention. Transcatheter closure of VSD with Lifetech Konar-MF device is safe and effective in infants less than 10 kg via only venous access with a high success rate and low complication rate. In these patients, transcatheter VSD closure can be performed by excluding the risk of complications that may occur due to AV loop formation, arterial intervention, endotracheal intubation and TEE use.

Indexed as

Atrioventricular BlockHeart Septal Defects, VentricularSeptal Occluder DeviceCardiac CatheterizationHeart Conduction SystemHumansInfantProstheses and ImplantsTreatment OutcomeInfantKONAR-multifunctional occluderTranscatheter interventionVentricular septal defect

Identifiers

PMID38081968
OpenAlexW4389547795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.